SCHEMBL7991648

SCHEMBL7991648

O=c1[nH]c(-c2ccncc2)nc2ncn(CCCc3ccccc3)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.54
POLB P06746 1/20 0.54
MAPK1 P28482 1/20 0.54
CNOT7 Q9UIV1 3/20 0.47
TSHR P16473 1/20 0.45
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GRIA1 P42261 2/20 0.43
GRIA2 P42262 2/20 0.43
GRIA3 P42263 2/20 0.43
GRIA4 P48058 2/20 0.43
GSK3B P49841 3/20 0.42
KMT2A Q03164 1/20 0.42
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991672 0.93 CNOT7 (0.46) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7984240 0.93 LMNA (0.58) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7974041 0.89 KDM4E (0.51) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7984488 0.88 LMNA (0.53) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7985608 0.88 LMNA (0.53) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7974445 0.86 ALDH1A1 (0.56) CNOT7ALDH1A1HPGDMAPTALOX15
SCHEMBL7974613 0.86 CNOT7 (0.49) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7988799 0.85 LMNA (0.54) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7986351 0.83 KDM4E (0.50) KDM4ELMNAPOLBMAPK1CNOT7
SCHEMBL7992300 0.83 LMNA (0.50) KDM4ELMNAPOLBMAPK1CNOT7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed